Erratum: The antifungal and anti-pneumocystis activities of the novel compound A3IS (Mycosinate) (Antimicrobial Agents and Chemotherapy (2022) 66:8 (e00521-22) DOI: 10.1128/aac.00521-22)

Nathan P. Wiederhold, Thomas F. Patterson, Sandra Rebholz, James Brennan, Thomas Patton, John Barrett, Connell W.C. Boal, Monika Ehrensberger, Ryan Boyle, Melanie T. Cushion

Research output: Contribution to journalComment/debatepeer-review

Abstract

Volume 66, no. 8, e00521-22, 2022, https://doi.org/10.1128/aac.00521-22. James Brennan, Thomas Patton, and John Barrett were not included in the byline in the original article. The byline and affiliation line should appear as shown above.

Original languageEnglish (US)
JournalAntimicrobial agents and chemotherapy
Volume67
Issue number2
DOIs
StatePublished - Feb 2023

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Infectious Diseases
  • Pharmacology

Fingerprint

Dive into the research topics of 'Erratum: The antifungal and anti-pneumocystis activities of the novel compound A3IS (Mycosinate) (Antimicrobial Agents and Chemotherapy (2022) 66:8 (e00521-22) DOI: 10.1128/aac.00521-22)'. Together they form a unique fingerprint.

Cite this